We have developed noninvasive, blood-based, quantitative tests that assess liver health by measuring critical liver cell processes and blood flow to the liver.  Our test results support healthcare providers’ clinical decisions to achieve more effective management of patients with advanced liver disease. HepQuant DuO testing delivers a Disease Severity Index (DSI), assessing a patient’s current level of liver impairment and disease state. Results may be used by healthcare providers in conjunction with other clinical tools to aid in the decision to defer invasive procedures or to evaluate a patient’s risk for clinical complications and disease progression